Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study

BACKGROUND: With many atypical antipsychotics now available in the market, it has become a common clinical practice to switch between atypical agents as a means of achieving the best clinical outcomes. This study aimed to examine the impact of switching from olanzapine to risperidone and vice versa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jihyung, Novick, Diego, Brugnoli, Roberto, Karagianis, Jamie, Dossenbach, Martin, Haro, Josep Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536691/
https://www.ncbi.nlm.nih.gov/pubmed/23206324
http://dx.doi.org/10.1186/1471-244X-12-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536691/
https://www.ncbi.nlm.nih.gov/pubmed/23206324
http://dx.doi.org/10.1186/1471-244X-12-218

Ejemplares similares